Skip to main content
. 2020 Dec 19;96(2):188–198. doi: 10.1002/ajh.26045

TABLE 1.

Participant demographics and baseline characteristics

Variable Patients
N = 1507
Mean (SD) age a , years 46.9 (16.22)
Mean (SD) age of retired ITP patients, years (n = 278) 68.2 (7.66)
Female, n (%) 975 (65)
Median (IQR) length of time with ITP, years 5 (2–12)

Patient self‐reported current health state (n = 1503)

(7‐point Likert scale; 7 is excellent health), n (%)

1–3 (low) 225 (15)
4 321 (21)
5–7 (high) 957 (64)
Route of patient recruitment, n (%)
Patient association group‐invited 855 (57)
Physician‐invited 652 (43)
Splenectomized, n (%) (n = 1325) 263 (20)
Symptom burden at diagnosis, n (%) (n = 1234)
Low 374 (30)
Moderate 270 (22)
High 282 (23)
Very high 308 (25)
Current employment status, n (%)
Working full‐time 661 (44)
Working part‐time 235 (16)
Retired 278 (18)
Homemaker 102 (7)
Student 68 (5)
Not working, not seeking employment 66 (4)
On long‐term sick leave or on disability 48 (3)
Not working, seeking employment 37 (2)
Other (no details) 12 (1)
Physicians
N = 472
Specialty, n (%)
Hematology 313 (66)
Hematology‐oncology 159 (34)
Current ITP caseload
Low (0–11 patients) 154 (33)
Moderate (12–30 patients) 146 (31)
High (31+ patients) 172 (36)
Patient caseload (ITP and non‐ITP), mean (SD) 454 (643)
ITP patient caseload, mean (SD)
ITP patients at time of survey completion 34 (50)
ITP patients in the 12 months prior to survey completion 43 (70)
Newly‐diagnosed ITP patients in the 12 months prior to survey completion 18 (36)
Clinical setting, n (%)
University/teaching hospital 265 (56)
Regional/community hospital 121 (26)
Private hospital 39 (8)
Specialist cancer center 32 (7)
Other 9 (2)
Office‐based 6 (1)
Year qualified, n (%)
Before 1981 11 (2)
1981–1993 95 (20)
1994–2003 172 (36)
2004–2014 171 (36)
After 2014 23 (5)
a

N = 1506.

Abbreviation: ITP, immune thrombocytopenia; IQR, interquartile range.